MBMV invests in international bio-tech startup Arcensus GmbH
Hoboken, NJ, Rostock/Berlin, Germany, Feb 22, 2022 – (ACN Newswire) – Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart diseases at the earliest stage in order to start preventive and personalized treatment. One year after Arcensus was founded, fresh capital is now being... » read more